Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives

Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives

With the development of nanotechnology and confronting the problems of traditional pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have attracted interest. Inhalable nano-formulations for treating lung diseases allow for precise pulmonary drug delivery, overcoming...

Full description

Bibliographic Details
Main Authors:	Siyuan Peng, Wenhao Wang, Rui Zhang, Chuanbin Wu, Xin Pan, Zhengwei Huang
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Pharmaceutics
Subjects:	inhalable nano-formulations inhalation devices industrialization nebulizers
Online Access:	https://www.mdpi.com/1999-4923/16/2/161

Similar Items

Practical, regulatory and clinical considerations for development of inhalation drug products
by: Shuguang Hou, et al.
Published: (2015-12-01)

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
by: Deepak Talwar, et al.
Published: (2021-01-01)

Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer
by: Kelly McDermott, BS, RRT-ACCS, et al.
Published: (2021-01-01)

Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future …
by: Guillaume Desoubeaux, et al.
Published: (2020-06-01)

Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation
by: Ching-Yi Liu, et al.
Published: (2019-09-01)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
by: Niamh Woods, et al.
Published: (2020-09-01)

Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children
by: S. La Grutta, et al.
Published: (2016-02-01)

Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery
by: Adam J. Plaunt, et al.
Published: (2022-01-01)

Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
by: Argyri Petrocheilou, et al.
Published: (2020-09-01)

New opportunities for nebulizer therapy in children
by: Yu. L. Mizernitsky
Published: (2019-02-01)

Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children
by: Zhou Y, et al.
Published: (2018-05-01)

Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects
by: Meiling Zheng, et al.
Published: (2024-03-01)

A comparison of the costs of bronchodilator delivery methods in children with asthma exacerbations treated in hospital. The first Polish study in children
by: Kamil Janeczek, et al.
Published: (2020-09-01)

Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery
by: Ali Al-Jipouri, et al.
Published: (2023-01-01)

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease
by: Cibelle Andrade Lima, et al.
Published: (2023-05-01)

Use of a vibrating mesh nebulizer for allergen challenge
by: Donald W. Cockcroft, et al.
Published: (2019-11-01)

Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study
by: Tamila V Martynyuk
Published: (2019-06-01)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
by: Shen Nam Cheng, et al.
Published: (2020-11-01)

Advances in Pulmonary Drug Delivery
by: Ayca Yıldız-Peköz, et al.
Published: (2020-09-01)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01)

Dataset on exposure conditions to Fe2O3 and SiO2 colloidal suspension and airborne particulate matter (PM) suspensions: crude NIST1648a and with reduced content of organic matter, LAp120
by: Monika Jankowska-Kieltyka, et al.
Published: (2024-04-01)

Nebulized heparin for burned patients with inhalation injury: a review
by: Tiberiu Paul Neagu, et al.
Published: (2022-03-01)

Inhalation properties of water-soluble drug loaded liposomes atomized by nebulizer
by: Shinshu Unida, et al.
Published: (2016-02-01)

Low-Frequency Intrapulmonary Percussive Ventilation Increases Aerosol Penetration in a 2-Compartment Physical Model of Fibrotic Lung Disease
by: Sandrine Le Guellec, et al.
Published: (2020-08-01)

COMPARAÇÃO DE DUAS TÉCNICAS INALATÓRIAS PARA ADMINISTRAR BRONCODILATADOR EM CRIANÇAS E ADOLESCENTES COM CRISE AGUDA DE ASMA: METANÁLISE
by: Cristian Roncada, et al.
Published: (2018-07-01)

Comparison of Salbutamol Delivered Via Jet Nebulizer With A Metered Dose Inhaler (MDI) Plus A Spacer for Asthma Exacerbation of Children: A Randomized Clinical Trial
by: Seyyed Ahmad Tabatabaii, et al.
Published: (2020-05-01)

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®
by: Jill A. Ohar, et al.
Published: (2020-08-01)

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis
by: Sofia Tejada, et al.
Published: (2022-02-01)

Assessment of Inhalation Technique in Clinical and Functional Control of Asthma and Chronic Obstructive Pulmonary Disease
by: Tiago Maricoto, et al.
Published: (2015-10-01)

Editorial: Strategies to overcome the barriers to effective inhaled treatments
by: Philip Chi Lip Kwok, et al.
Published: (2023-07-01)

The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022-01-01)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
by: Renée VE. Dagenais, et al.
Published: (2022-01-01)

The Effect of Nebulized Furosemide in Patients with Acute Cardiogenic Pulmonary Edema: A Randomized Clinical Trial
by: Babak Mahshidfar, et al.
Published: (2018-12-01)

Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
by: Iching G. Yu, et al.
Published: (2021-04-01)

Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
by: Ergin Arslanoğlu, et al.
Published: (2024-04-01)

Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery
by: Frédéric Tewes, et al.
Published: (2020-06-01)

A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects
by: Sawittree Sahakijpijarn, et al.
Published: (2021-05-01)

Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians... perspective
by: S.G. Theodorakis, et al.
Published: (2023-01-01)

Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
by: Qianyu Wan, et al.
Published: (2023-07-01)

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with <span style="font-variant: small-caps">L</span>-Leucine or Trileucine
by: Imco Sibum, et al.
Published: (2019-12-01)